24th Jul 2019 10:00 am |
RNS |
Non-Executive Chairman |
22nd Jul 2019 5:00 pm |
RNS |
ViiV presents 96-week data from phase III study |
15th Jul 2019 6:19 pm |
RNS |
Director/PDMR Shareholding |
15th Jul 2019 6:18 pm |
RNS |
Director/PDMR Shareholding |
15th Jul 2019 6:16 pm |
RNS |
Director/PDMR Shareholding |
15th Jul 2019 11:42 am |
RNS |
Director/PDMR Shareholding |
15th Jul 2019 7:00 am |
RNS |
positive results in Phase 3 PRIMA study of ZEJULA |
12th Jul 2019 4:35 pm |
RNS |
Director/PDMR Shareholding |
12th Jul 2019 3:55 pm |
RNS |
Director/PDMR Shareholding |
10th Jul 2019 3:48 pm |
RNS |
Director/PDMR Shareholding |
10th Jul 2019 7:00 am |
RNS |
ViiV switch study shows 2DR as effective as 3DR |
1st Jul 2019 12:08 pm |
RNS |
Total Voting Rights |
12th Jun 2019 5:10 pm |
RNS |
Director/PDMR Shareholding |
7th Jun 2019 7:00 am |
RNS |
FDA approval for Nucala self-administration |
4th Jun 2019 8:00 am |
RNS |
CHMP positive on GSK's Nucala self-administration |
3rd Jun 2019 2:31 pm |
RNS |
Total Voting Rights |
24th May 2019 10:54 am |
RNS |
Director/PDMR Shareholding |
20th May 2019 1:44 pm |
RNS |
Director/PDMR Shareholding |
13th May 2019 5:44 pm |
RNS |
Block listing Interim Review |
13th May 2019 4:19 pm |
RNS |
Director/PDMR Shareholding |
8th May 2019 6:23 pm |
RNS |
Result of AGM & GM |
2nd May 2019 5:07 pm |
RNS |
Trelegy Ellipta asthma study met primary endpoint |
1st May 2019 3:11 pm |
RNS |
Director/PDMR Shareholding |
1st May 2019 2:32 pm |
RNS |
Total Voting Rights |
1st May 2019 12:00 pm |
RNS |
1st Quarter Results |
29th Apr 2019 12:00 pm |
RNS |
ViiV submits NDA for HIV monthly 2 drug injectable |
26th Apr 2019 4:16 pm |
RNS |
ViiV receives CHMP Positive Opinion for Dovato |
16th Apr 2019 5:36 pm |
RNS |
Director/PDMR Shareholding |
16th Apr 2019 5:35 pm |
RNS |
Director/PDMR Shareholding |
16th Apr 2019 5:23 pm |
RNS |
Director/PDMR Shareholding |
16th Apr 2019 5:14 pm |
RNS |
Director/PDMR Shareholding |
15th Apr 2019 2:45 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2019 4:47 pm |
RNS |
Director/PDMR Shareholding |
12th Apr 2019 4:33 pm |
RNS |
Director/PDMR Shareholding |
11th Apr 2019 5:01 pm |
RNS |
Director/PDMR Shareholding |
9th Apr 2019 7:00 am |
RNS |
FDA approves ViiV's two-drug HIV regimen, Dovato |
2nd Apr 2019 1:00 pm |
RNS |
Publication of AGM and GM Shareholder Documents |
1st Apr 2019 4:36 pm |
RNS |
Total Voting Rights |
28th Mar 2019 4:15 pm |
RNS |
GSK reporting changes - product sales and IFRS 16 |
25th Mar 2019 5:02 pm |
RNS |
Director/PDMR Shareholding |